Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Melissa Lambert

Physician Assistant, Medical Hendersonville, TN Physician Assistant

NPI 1922287564 CMS profile 10726988

190D Saundersville Rd Ste 2005, Hendersonville, TN 37075

Open in the dashboard

General payments

$47,265

1,017 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Melissa Lambert of Hendersonville, TN is reported in the CMS Open Payments database as having received $47,265 across 1,017 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $19,167 317
2024 General $14,094 274
2023 General $8,234 190
2022 General $3,299 124
2021 General $2,472 112

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Melissa Lambert
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Melissa Lambert were reported at $19,167. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Melissa Lambert Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $2,472 $156 $41–$563 $132
2022 $3,299 $185 $55–$649 $149
2023 $8,234 $199 $58–$717 $160
2024 $14,094 $206 $62–$740 $164
2025 $19,167 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. LEO Pharma Inc. $15,065 114 payments
  2. Sun Pharmaceutical Industries Inc. $8,393 79 payments
  3. Arcutis Biotherapeutics, Inc. $4,919 37 payments
  4. AbbVie, Inc. $2,401 119 payments
  5. Novartis Pharmaceuticals Corporation $1,758 45 payments
  6. Janssen Biotech, Inc. $1,751 93 payments
  7. Genzyme Corporation $1,652 55 payments
  8. Incyte Corporation $1,176 40 payments
  9. Lilly USA, LLC $1,145 41 payments
  10. E.R. Squibb & Sons, L.L.C. $1,143 61 payments
  11. Other $7,863 333 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $22,313 970 payments
  2. Consulting Fee $10,443 12 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $6,294 7 payments
  4. Travel and Lodging $3,687 9 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $3,645 3 payments
  6. Education $883 16 payments
Products named General payments · program years 2021–2025
  1. ADBRY $9,536 83 payments
  2. ILUMYA $7,659 52 payments
  3. ANZUPGO $6,920 23 payments
  4. DUPIXENT $2,169 87 payments
  5. TREMFYA $1,745 86 payments
  6. COSENTYX $1,533 30 payments
  7. SKYRIZI $1,220 55 payments
  8. OPZELURA $1,176 40 payments
  9. SOTYKTU $1,078 60 payments
  10. Bimzelx $970 50 payments
  11. Other $11,915 577 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 23 drugs

Part D claims

1,068

Median for Physician Assistant: 241

Drug cost

$77,781

Median for Physician Assistant: $4,110

Branded share of claims

8.1%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Dupixent Pen Dupilumab Brand 13 $49,744
Clobetasol Propionate Generic 216 $8,804
Fluorouracil Generic 39 $3,727
Tacrolimus Generic 14 $2,435
Doxycycline Hyclate Generic 85 $2,292
Ketoconazole Generic 102 $1,620
Triamcinolone Acetonide Generic 80 $1,198
Metronidazole Generic 24 $1,016
Mupirocin Generic 106 $809
Ciclopirox Ciclopirox Olamine Brand 38 $786

The 10 drugs with the highest cost, of 23 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 59 billing codes

Paid by Medicare

$102,291

Of which drugs: $16,540

Medicare patients

557

Average age 75

Services billed

2,392

319 women, 238 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 46%
Ischemic heart disease 33%
Diabetes 27%
Chronic kidney disease 26%
Depression 19%
Atrial fibrillation 16%
Cancer 15%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) J7308 Office 34 56 $16,522

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 27 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ADBRY
$5,248 — —
ILUMYA
$2,161 — —
COSENTYX
$1,167 — —
TREMFYA
$602 — —
SKYRIZI
$450 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 27 with Patron

Records

1,017 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record